{
    "2018-03-02": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Sanofiâ€™s Established Prescription Products in 4Q17",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Prescription",
                        "Products",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Novo Nordisk CEO Sees Competition in U.S. Driving Down Prices",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "CEO",
                        "Competition",
                        "U.S.",
                        "Prices"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}